Literature DB >> 29219060

Nattokinase: an updated critical review on challenges and perspectives.

Ethiraj Selvarajan1, Niharika Bhatnagar1.   

Abstract

Natto, a fermented soybean food, has been consumed by oriental people for more than 1000 years. Nattokinase, formerly called subtilisin NAT is a well studied protease of microbial origin that possesses fibrinolytic (anti-clotting) activities. Due to its strong fibrinolytic and thrombolytic activity, Nattokinase is regarded as a precious dietary supplement or nutraceutical for the oral thrombolytic therapy. Nattokinase is witnessed to be a useful enzyme for the com-plete removal of the vitreous and associated proliferative tissues in proliferative vitreo retinal disorders. This review focuses on the native and recombinant Nattokinase from bacteria and other sources, their production, purification, immobilization and nano-immobilization studies, which aid in ameliorating their properties to suit the targeted industrial applications. Recent development in these fields are presented and discussed, and prospective developments are suggested. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Nano immobilization; Nattokinase; cardiovascular disease; fibrinolytic enzymes; recombinant nattokinase.

Year:  2017        PMID: 29219060     DOI: 10.2174/1871525716666171207153332

Source DB:  PubMed          Journal:  Cardiovasc Hematol Agents Med Chem        ISSN: 1871-5257


  3 in total

Review 1.  Recent Advances in Nattokinase-Enriched Fermented Soybean Foods: A Review.

Authors:  Danfeng Li; Lizhen Hou; Miao Hu; Yaxin Gao; Zhiliang Tian; Bei Fan; Shuying Li; Fengzhong Wang
Journal:  Foods       Date:  2022-06-24

2.  Nattokinase-Associated Hemoperitoneum in an Elderly Woman.

Authors:  Lintu Ramachandran; Ammar Aqeel; Ali Jafri; Yadwinder Sidhu; Taha Mohamed Djirdeh
Journal:  Cureus       Date:  2021-12-01

Review 3.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.